Roivant Sciences (ROIV) Non-cash Items (2022 - 2025)
Roivant Sciences (ROIV) reported Non-cash Items of $113.0 million for Q2 2025, up 7.94% on a YoY basis from $104.7 million in Q2 2024, and up 2.11% quarter-over-quarter from $110.7 million in Q1 2025.
Roivant Sciences (ROIV) Non-cash Items (2022 - 2025) Analysis & Trends
Roivant Sciences has reported Non-cash Items for 4 years, with the latest figure at $113.0 million in Q2 2025.
- For the quarter ending Q2 2025, Non-cash Items rose 7.94% year-over-year to $113.0 million; the trailing twelve-month figure through Jun 2025 stood at $113.0 million (up 7.94% YoY), and the FY2025 full-year result was $110.7 million, down 77.84% from the prior year.
- Non-cash Items for Q2 2025 stood at $113.0 million, up from $110.7 million in the prior quarter.
- The five-year high for Non-cash Items was $499.5 million in Q1 2024, with the low at $1.9 million in Q1 2022.
- Historically, Non-cash Items has averaged $130.4 million across 4 years, with a median of $104.7 million in 2024.
- Annual changes were most pronounced in 2023 — Non-cash Items surged 14653.61% — and 2025, when it plunged 77.84%.
- Roivant Sciences' Non-cash Items stood at $55.6 million in 2022, then soared by 64.78% to $91.7 million in 2023, then climbed by 17.24% to $107.5 million in 2024, then increased by 5.16% to $113.0 million in 2025.
- The last three Non-cash Items figures came in at $113.0 million (Q2 2025), $110.7 million (Q1 2025), and $107.5 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Roivant Sciences | 21.82 Bn | 22.59 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 113.03 Mn |
| Jun 30, 2025 | 113.03 Mn |
| Mar 31, 2025 | 110.69 Mn |
| Mar 31, 2025 | 110.69 Mn |
| Dec 31, 2024 | 107.48 Mn |
| Dec 31, 2024 | 107.48 Mn |
| Sep 30, 2024 | 107.64 Mn |
| Sep 30, 2024 | 107.64 Mn |
| Jun 30, 2024 | 104.71 Mn |
| Jun 30, 2024 | 104.71 Mn |
| Mar 31, 2024 | 499.49 Mn |
| Mar 31, 2024 | 499.49 Mn |
| Dec 31, 2023 | 91.67 Mn |
| Dec 31, 2023 | 91.67 Mn |
| Sep 30, 2023 | 86.58 Mn |
| Sep 30, 2023 | 86.58 Mn |
| Jun 30, 2023 | 84.26 Mn |
| Jun 30, 2023 | 84.26 Mn |
| Mar 31, 2023 | 280.17 Mn |
| Mar 31, 2023 | 280.17 Mn |